Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 221

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 221
---
         
 provided, further, that references in certain sections of this Agreement to dollar amounts are not intended to be, and shall not be deemed to be, illustrative or interpretative for purposes of determining whether a Material Adverse Change has        
 occurred;                                                                                                                                                                                                                                                 |

A-12

| (bbbb) | “Material Contract” means, collectively, the material Contracts of the Company and its                                                                                                                                                                  
 Subsidiary set out in Schedule 19 to the Disclosure Letter, and any and all other Contracts, commitments, agreements (written or oral), instruments, leases or other documents or arrangements to which the Company or its Subsidiary are a party or to 
 which their properties or assets are otherwise bound, and which are material to the Company and its Subsidiary, taken as a whole, other than, in each case, any Employee Plan;                                                                          |

| (cccc) | “material fact” has the meaning ascribed thereto in the Securities Act 
 (Québec);                                                              |

| (dddd) | “Meeting” means the special meeting of Shareholders, including any adjournment or                                                                                                       
 postponement of such special meeting in accordance with the terms of this Agreement, to be called and held in accordance with the Interim Order to consider the Arrangement Resolution; |

| (eeee) | “Meeting Deadline” has the meaning specified in Section 2.5(a); |

| (ffff) | “MI 61-101” means Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions; |

| (gggg) | “Misrepresentation” has the meaning specified in the Securities Act (Québec); |

| (hhhh) | “Nasdaq” means the Nasdaq Capital Market exchange or any successor thereto; |

| (iiii) | “NI 62-104” means National Instrument 62-104 – Take-Over Bids and Issuer Bids; |

| (jjjj) | “Option Plan” means the Repare Therapeutics Inc. Amended and Restated Option Plan; |

| (kkkk) | “Options” means outstanding options to acquire Common Shares under the Option Plan or the 
 Equity Incentive Plan, as applicable;                                                     |

| (llll) | “Order” means all judicial, arbitral, administrative, ministerial, departmental or                                                                                                                                                                   
 regulatory judgments, injunctions, orders, decisions, rulings, determinations, awards, decrees, stipulations or similar actions taken